Aspirin withdrawal in acute peptic ulcer bleeding: Are we harming patients?

Annals of Internal Medicine

Volumn 152, Issue 1, 2010, Pages 52-53

  Barkun, Alan N ^a,c   Bardou, Marc ^b  

^a MCGILL UNIVERSITY   (Canada)

^b DIJON UNIVERSITY HOSPITAL   (France)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO; PROTON PUMP INHIBITOR;

ANTICOAGULANT THERAPY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDICATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; HUMAN; LOW DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RISK BENEFIT ANALYSIS; TREATMENT WITHDRAWAL; UPPER GASTROINTESTINAL BLEEDING;

EID: 74849091358     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-1-201001050-00183     Document Type: Editorial

References (15)

1. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, et al; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008;118:1894-909. [PMID: 18836135]
2. Lanas A, García-Rodr?́guez LA, Polo-Tomás M, Ponce M, Alonso-Abreu I, Perez-Aisa MA, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104: 1633-41. [PMID: 19574968]
3. Barkun A, Sabbah S, Enns R, Armstrong D, Gregor J, Fedorak RN, et al; RUGBE Investigators. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol. 2004;99:1238-46. [PMID: 15233660]
4. Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding. A randomized trial. Ann Intern Med. 2010;152:1-9.
5. Chiu PW, Ng EK, Cheung FK, Chan FK, Leung WK, Wu JC, et al. Predicting mortality in patients with bleeding peptic ulcers after therapeutic endoscopy. Clin Gastroenterol Hepatol. 2009;7:311-6; quiz 253. [PMID: 18955161]
6. Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001;52:349-55. [PMID: 11678778]
7. Li Y, Sha W, Nie Y, Wu H, She Q, Dai S, et al. Effect of intragastric pH on control of peptic ulcer bleeding. J Gastroenterol Hepatol. 2000;15:148-54. [PMID: 10735538]
8. Biondi-Zoccai GG, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. ur Heart J. 2006;27:2667-74. [PMID: 17053008]
9. Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62:1187-9. [PMID: 15079022]
10. Burger W, Chemnitius JM, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005;257:399-414. [PMID: 15836656]
11. Aguejouf O, Eizayaga F, Desplat V, Belon P, Doutremepuich C. Prothrombotic and hemorrhagic effects of aspirin. Clin Appl Thromb Hemost. 2008. [PMID: 18603541]
12. Rostom A, Moayyedi P, Hunt R; Canadian Association of Gastroenterology Consensus Group. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther. 2009;29:481-96. [PMID: 19053986]
13. Barkun AN, Bardou M, Kuipers EJ, Sung J, Hunt RH, Martel M, et al. International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med. 2010;152. [Forthcoming].
14. Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, et al. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding. N Engl J Med. 2005;352:238-44. [PMID: 15659723]
15. Lai KC, Chu KM, Hui WM, Wong BC, Hung WK, Loo CK, et al. Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications. Clin Gastroenterol Hepatol. 2006;4:860-5. [PMID: 16797240]